-
Taxonomy & unit
-
us-gaap: USD/shares
-
Description
-
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
-
Summary
-
Keros Therapeutics, Inc. quarterly/annual Earnings Per Share, Basic history and growth rate from 2020 to 2023.
- Keros Therapeutics, Inc. Earnings Per Share, Basic for the quarter ending September 30, 2024 was -1.41 USD/shares, a 6.02% decline year-over-year.
- Keros Therapeutics, Inc. Earnings Per Share, Basic for the twelve months ending September 30, 2024 was -5.21 USD/shares, a 5.25% decline year-over-year.
- Keros Therapeutics, Inc. annual Earnings Per Share, Basic for 2023 was -5.2 USD/shares, a 25.3% decline from 2022.
- Keros Therapeutics, Inc. annual Earnings Per Share, Basic for 2022 was -4.15 USD/shares, a 64.7% decline from 2021.
- Keros Therapeutics, Inc. annual Earnings Per Share, Basic for 2021 was -2.52 USD/shares, a 14% increase from 2020.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Growth (%)